世界最新医学信息文摘（电子版）
世界最新醫學信息文摘（電子版）
세계최신의학신식문적（전자판）
World Latest Medicine Information
2014年
11期
21-22
,共2页
李国良%张志捧%梁冬梅%王强
李國良%張誌捧%樑鼕梅%王彊
리국량%장지봉%량동매%왕강
新生血管性青光眼%引流阀植入%全视网膜光凝
新生血管性青光眼%引流閥植入%全視網膜光凝
신생혈관성청광안%인류벌식입%전시망막광응
neovascular glaucoma%valve implantation%panretinal photocoagulation
目的：观察青光眼引流阀植入联合全视网膜光凝治疗新生血管性青光眼的临床效果。方法回顾性分析2009年1月至2013年1月在我院眼科接受治疗的新生血管性青光眼患者52例，依据治疗方法不同随机分为对照组与观察组，其中对照组采用青光眼引流阀植入治疗新生血管性青光眼26例，观察组采用青光眼引流阀植入联合全视网膜光凝治疗新生血管性青光眼26例，记录术前、术后眼压及并发症。结果对照组26例中一次手术成功21例（80.77%），接受2次手术并成功5例（19.23%）；术前平均眼压为（54.5±12.8）mmHg,术后1周平均（15.2±6.9）mmHg,观察组26例中一次手术成功24例（92.31%），接受2次手术并成功2例（7.69%）；术前平均眼压为（53.5±8.6）mmHg,术后1周平均（10.6±4.5）mmHg,两组术后与术前相比差异均具有显著统计学意义（P ＜0.05）。结论青光眼引流阀植入联合全视网膜光凝治疗新生血管性青光眼的临床效果确切、安全有效，值得临床推广应用。
目的：觀察青光眼引流閥植入聯閤全視網膜光凝治療新生血管性青光眼的臨床效果。方法迴顧性分析2009年1月至2013年1月在我院眼科接受治療的新生血管性青光眼患者52例，依據治療方法不同隨機分為對照組與觀察組，其中對照組採用青光眼引流閥植入治療新生血管性青光眼26例，觀察組採用青光眼引流閥植入聯閤全視網膜光凝治療新生血管性青光眼26例，記錄術前、術後眼壓及併髮癥。結果對照組26例中一次手術成功21例（80.77%），接受2次手術併成功5例（19.23%）；術前平均眼壓為（54.5±12.8）mmHg,術後1週平均（15.2±6.9）mmHg,觀察組26例中一次手術成功24例（92.31%），接受2次手術併成功2例（7.69%）；術前平均眼壓為（53.5±8.6）mmHg,術後1週平均（10.6±4.5）mmHg,兩組術後與術前相比差異均具有顯著統計學意義（P ＜0.05）。結論青光眼引流閥植入聯閤全視網膜光凝治療新生血管性青光眼的臨床效果確切、安全有效，值得臨床推廣應用。
목적：관찰청광안인류벌식입연합전시망막광응치료신생혈관성청광안적림상효과。방법회고성분석2009년1월지2013년1월재아원안과접수치료적신생혈관성청광안환자52례，의거치료방법불동수궤분위대조조여관찰조，기중대조조채용청광안인류벌식입치료신생혈관성청광안26례，관찰조채용청광안인류벌식입연합전시망막광응치료신생혈관성청광안26례，기록술전、술후안압급병발증。결과대조조26례중일차수술성공21례（80.77%），접수2차수술병성공5례（19.23%）；술전평균안압위（54.5±12.8）mmHg,술후1주평균（15.2±6.9）mmHg,관찰조26례중일차수술성공24례（92.31%），접수2차수술병성공2례（7.69%）；술전평균안압위（53.5±8.6）mmHg,술후1주평균（10.6±4.5）mmHg,량조술후여술전상비차이균구유현저통계학의의（P ＜0.05）。결론청광안인류벌식입연합전시망막광응치료신생혈관성청광안적림상효과학절、안전유효，치득림상추엄응용。
Objective to observe the clinical effect of glaucoma drainage valve implantation combined with retinal photocoagulation in treatment of neovascular glaucoma. Methods a retrospective analysis of 52 patients with neovascular glaucoma from 2009 January to 2013 January in our hospital department of ophthalmology patients, according to the different treatment methods were randomly divided into control group and observation group, the control group was treated with glaucoma valve implantation in the treatment of neovascular glaucoma in 26 cases, the observation group was treated with glaucoma valve implantation combined with retinal light coagulation treatment of 26 cases of neovascular glaucoma, recorded before operation, postoperative intraocular pressure and complications. Results 21 cases of control group a successful operation in 26 cases (80.77%), received the 2 operation was successful in 5 cases (19.23%); the average preoperative intraocular pressure was (54.5 ± 12.8) mmHg, after 1 weeks in average (15.2 ± 6.9) mmHg, the observation group of 26 cases in one operation was successful in 24 cases (92.31%), received the 2 operation was successful in 2 cases (7.69%); the average preoperative intraocular pressure was (53.5 ± 8.6) mmHg, after 1 weeks in average (10.6 ± 4.5) mmHg, two groups compared to the preoperative and postoperative differences were statistically significant (P < 0.05). Conclusion the clinical effect of glaucoma valve implantation combined with retinal photocoagulation in treatment of neovascular glaucoma is exact, safe and effective, worthy of clinical application.
